Company Profile:
CENTRAL PHARMA (Indonesia) is a trader.
Company Introduction:
CENTRAL PHARMA (often referring to PT Central Pharma) is a pharmaceutical trading and distribution company based in Indonesia. Its primary activities involve the procurement, storage, and distribution of pharmaceutical products, medical devices, and healthcare products. The company plays a significant role in Indonesia's pharmaceutical supply chain, responsible for delivering various medical products from manufacturers to hospitals, pharmacies, and other healthcare institutions. CENTRAL PHARMA is committed to providing efficient and reliable pharmaceutical distribution services, ensuring product quality and timely supply across the region.
Enterprise Products
PT Central Pharma, Indonesia, manufactures and sells a wide range of pharmaceutical products. These include:
Antimicrobials such as Cefadroxil, Amoxicillin, Ciprofloxacin, Doxycycline, and Metronidazole.
Analgesics and Antipyretics including Paracetamol, Ibuprofen, and Diclofenac.
Anti-inflammatory drugs like Diclofenac and Ibuprofen.
Respiratory system medications such as Salbutamol and Bromhexine.
Gastrointestinal system medications including Omeprazole and Ranitidine.
Cardiovascular system medications like Amlodipine and Simvastatin.
Vitamins and Supplements, for example, Vitamin C, Vitamin B Complex, and Multivitamins.
Anti-allergy medications such as Loratadine and Cetirizine.
Dermatological preparations including Hydrocortisone Cream and Miconazole Cream.
They also offer products in the categories of Central Nervous System drugs, Urogenital system medications, and Anthelmintics (antiparasitic drugs).